Marker Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Marker Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Marker Therapeutics Inc
Rating: 1.58300
Author: Trendlyne DVM scores

about

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...

1.46 0.03 (2.10%)

64.13% Fall from 52W High

51,608

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The board meeting for Marker Therapeutics Inc is scheduled for today, for the purpose of Marker Therapeutics Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

11.5 / 100

Technically Neutral

51.8 / 100

1Yr Price target upside is 439%

3 analysts

Marker Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Marker Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...

64.13% Fall from 52W High

SWOT Analysis

Marker Therapeutics Inc Live Price Chart